Sign in

CIK 0001521036

  • Large accelerated filer

Lantheus Holdings, Inc.

Sign in to watch
Ticker
LNTH
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
352318913
Phone
+1 978-671-8001
Business address
201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
Former names
Lantheus MI Holdings, Inc.
  1. 4 Planned sale Chief Accounting Officer sold 341 shares at $56.01 ($19,099)
  2. 4 Planned sale CFO and Treasurer sold 10,000 shares at $78.24 ($782,400)
  3. 4 Gift CEO gave 53,350 shares (gift)
  4. 4 Planned sale Chief Accounting Officer sold 341 shares at $75.62 ($25,786)
  5. 4 Planned sale President sold 1,500 shares at $67.96 ($101,940)
  6. 4 Planned sale CEO sold 11,780 shares at an average $63.72 ($750,611)
  7. 4 Planned sale Chief Accounting Officer sold 341 shares at $63.57 ($21,677)
  8. 4 Open-market sale Director sold 6 shares at $86.22 ($517)
  9. 4 Planned sale See Remarks sold 2,846 shares at $66.43 ($189,060)
  10. 4 Grant or award CFO and Treasurer acquired 4,872 shares (grant or award)
  11. 4 Planned sale President sold 408 shares at $66.10 ($26,969)
  12. 4 Planned sale President sold 1,500 shares at $65.19 ($97,785)
  13. 4 Planned sale CFO and Treasurer sold 10,000 shares at $68.52 ($685,200)
  14. 4 Planned sale CEO sold 10,950 shares at an average $68.58 ($750,981)
  15. 4 Planned sale See Remarks sold 4,297 shares at $67.93 ($291,895)
  16. 4 Planned sale Chief Accounting Officer sold 1,752 shares at $90.87 ($159,209)
  17. 4 Shares withheld for taxes President gave up 518 shares (to pay taxes)
  18. 4 Planned sale President sold 1,500 shares at $97.93 ($146,895)
  19. 4 Shares withheld for taxes See Remarks gave up 1,466 shares (to pay taxes)
  20. 4 Planned sale Chief Accounting Officer sold 385 shares at $99.36 ($38,254)

Page 8 of 30 · 598 filings